Home

Pharma China Web Edition

Pharma China Archives

Online Databases

Subscription/Order/Info

Event Calendar

China Pharma Providers

About Us

	News     The Market     Industry News     Regulatory News     General Health     Legal/IPR News     Product/R&D News     API/Bulk Drug News     People in the News     Other News     Top News Worldwide Feature articles     Featured News     Editorials     Commentaries     Expert Opinions     Interviews     Case Studies     Company Profiles     Editor´s Picks General Information Full Text Title

The Market Industry News Regulatory News General Health Legal/IPR News Product/R&D News API/Bulk Drug News People in the News Other News Top News Worldwide Featured News Editorials Commentaries Expert Opinions Interviews Case Studies Company Profiles Editor´s Picks

CNDA Solicits Comments on Draft Implementation Rules for Drug Test Data Protecti... As a part of the deepening reform of Chinese drug and medical device evaluation and approval system, and in order to enhance drug innovation and development of the generi... (4/26/2018) As India, China Drug Industries Mature, FDA Scrutiny an Overhang (4/26/2018) China to Test Data Monitoring System for Hospital Outpatients under Trial Scheme This Year (4/26/2018) Gibson: U.S.'s Growing Dependence on China For Vital Medicines A National Security Risk (4/24/2018) The Biosimilar Race in China (4/24/2018) Breaking News on New Policies of Innovative Drugs in China (4/19/2018) Chinese Money Floods U.S. Biotech as Beijing Chases New Cures (4/18/2018) China Announces New Initiatives to Level the Playing Field for Innovative and Generic Drugs (4/18/2018) U.S. Businesses Worried over Chinese Policy Initiative (4/17/2018) China Will Always Be Bad at Bioethics (4/17/2018) (free) Why Immuno-Therapy Is Leaving Markets Abuzz Across the World (4/17/2018) Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms Race (4/17/2018) Bloomburg: China Is Nationalizing Its Tech Sector (4/12/2018) PharmExec: China's CAR-T Therapy Race (4/10/2018) China Pushes Generics over Brands with Another Round of New Pharma Policies (4/6/2018) Biopharma Caught in the Crosshairs of U.S.-China Trade Tussle (4/6/2018) CNDA Solicits Comments on Draft Implemen...  (4/26/2018) CNDA Announces Relevant Matters on Custo...  (4/26/2018) CFDA Issues New Technical Guidelines for...  (4/26/2018) Entasis and Zai Lab Enter Strategic Deve...  (4/26/2018) Zoetis to Expand Its Animal Vaccine Rese...  (4/26/2018) (free) UCB Announces Filing Acceptance with the...  (4/26/2018) Two China Biotechs Drop U.S. IPO Plans f...  (4/26/2018) Adocia and Tonghua Dongbao Announce a St...  (4/26/2018) Lundbeck Launches Anti-depressant Brinte...  (4/25/2018) MSD's HPV Vaccine Gardasil 9 under Revie...  (4/25/2018) NCCD, Lilly China Enter Collaboration fo...  (4/24/2018) 30 Listed Chinese Pharma Cos Spent Over ...  (4/24/2018) Chinese PD Hospital Drug Market on Stead...  (4/24/2018) CPA Releases Topline Data of 2017 Hospit...  (4/24/2018) China Announces Import Tariff Reduction ...  (4/24/2018) CANbridge Receives IND Approval to Commence CAN008 Phase... Global Contract Pharmaceutical Manufacturing Market to R... White House Task Force Echoes Pharma Proposals Pharma Industry Reputation Rebounds Somewhat in 2016 Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA... Chinese PD Hospital Drug Market on Steady Growth of 10% CAGR 20... CPA Releases Topline Data of 2017 Hospital Drug Purchase Audit Nicholas Hall Projects Chinese OTC Drug Market to Grow 6% CAGR ... Nicholas Hall's Review of China's OTC Drug Market Performance 2... SMEI: Review of Chinese Terminal Drug Markets in 2010-2017 Entasis and Zai Lab Enter Strategic Development Partnership ... Zoetis to Expand Its Animal Vaccine Research and Manufacturi... Two China Biotechs Drop U.S. IPO Plans for $800M HK Listing Adocia and Tonghua Dongbao Announce a Strategic Alliance for... Lundbeck Launches Anti-depressant Brintellix in China CNDA Solicits Comments on Draft Implementation Rules for... CNDA Announces Relevant Matters on Custom Clearance of I... CFDA Issues New Technical Guidelines for Compatibility S... CNDA Issues Announcement over Matters Related to Import ... CDE Publicizes Batch 28 of Drug Applications To Be Grant... China to Restructure and Consolidate IP Regulatory Authoriti... Amended Patent Law Draft to Be Submitted for NPC Deliberatio... Novartis Entangled in New Bribery Allegation, Days After Its... Biotech Deals Targeted for More Scrutiny in New Trump Admini... UK Investigators Ask for New Info from GSK Relating to Its C... Trump's China Tariff Plan Target Dozens of Key APIs and ... Stada: Pollution Crackdown in China Led to Pharma Supply... India to Blacklist Eight Chinese Pharma Companies for Qu... EMA Bans Amoxicillin API from Changsheng Pharma after Id... Fast Rising Price of Chinese APIs Puts Pressure on Botto... UCB Announces Filing Acceptance with the CNDA for RA Dru... MSD's HPV Vaccine Gardasil 9 under Review in China Merck Group Receives Patent for CRISPR Technology in Chi... Sinovac Announces Preliminary Results of Phase III Trial... BeiGene Presents Clinical Data on Pamiparib in Chinese P... China Announces Import Tariff Reduction of Some Drugs in... China Publishes First Health Management Bluebook China to Roll Out New Measures to Boost Internet + Healt... State Council Removes Import Duties on Anticancers as It... State Council Lays Out Tasks in Healthcare and Pharmaceu... Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves 70 Chinese Pharma/Medical Device Entreprenuers on the Huru... China to Set Up Hainan Free Trade Zone, Further Benefiti... Upcoming Event: Pharma/Biotech Market Access & Prici... Upcoming Event: International Conference on Alzheimers, ... Upcoming Event: World Congress on Advancements in Proteo... Upcoming Event: International Conferences on Medical &am... Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector... WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Chi...   WiCON and PharmaGuys Launch Ph...   WiCON Officially Publishes Chi...   WiCON Officially Publishes Its...

© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links